Bisphosphonate associated osteonecrosis of the jaw.

AA, Khan; GK, Sándor; E, Dore; AD, Morrison; M, Alsahli; F, Amin; E, Peters; DA, Hanley; SR, Chaudry; B, Lentle; DW, Dempster; FH, Glorieux; AJ, Neville; RM, Talwar; CM, Clokie; MA, Mardini; T, Paul; S, Khosla; RG, Josse; S, Sutherland; DK, Lam; RP, Carmichael; N, Blanas; D, Kendler; S, Petak; LG, Ste-Marie; J, Brown; AW, Evans; L, Rios; JE, Compston

doi:10.3899/jrheum.080759

Public

Bisphosphonate associated osteonecrosis of the jaw.

Shared by NobleBlocks on Mar 1, 2009 • 12:00 AM UTC

Authors:

Khan AA

Sándor GK

Dore E

Abstract

In 2003, the first reports describing osteonecrosis of the jaw (ONJ) in patients receiving bisphosphonates (BP) were published. These cases occurred in patients with cancer receiving high-dose intravenous BP; however, 5% of the cases were in patients with osteoporosis receiving low-dose bisphosphona...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!